Unknown OBSERVATIONAL NCT01878955

The Use Of AMH for the Discrimination of Polycystic and Multicystic Ovaries in Nonhyperandrogenic Patients

Elevation of AMH Resulted From Ovarian Structural Properties or Effects of Gonadotropines

Sponsor: Izmir Katip Celebi University

Interventions AMH level difference between patient with PCOS and multicystic ovaries.

Updated 9 times since 2017 Last updated: Feb 28, 2018 Started: Feb 29, 2016 Primary completion: Dec 30, 2018 Completion: Dec 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Polycystic Ovary Syndrome, this trial is ongoing. The trial is conducted by Izmir Katip Celebi University and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Mar 2020 — Jan 2021 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Jun 2018 — Mar 2020 [monthly]

Active Not Recruiting

▶ Show 4 earlier versions

Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None
Mar 2018 — Apr 2018 [monthly]

Active Not Recruiting NA
Feb 2017 — Mar 2018 [monthly]

Active Not Recruiting NA
Jan 2017 — Feb 2017 [monthly]

Active Not Recruiting NA

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Izmir Katip Celebi University

Data source: Izmir Katip Celebi University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.